The launch environment has undergone huge changes as the pharmaceutical industry's focus has moved from primary care to specialty launch, but its future will be transformed even more radically. The advent of highly novel cell and gene therapies as well as prescription digital therapeutics is providing a serious set of forces for change in the market.
Other changes come from the challenges developed markets face, which renews the urgency for pharma companies to spread their launch successes beyond traditionally core markets.
The pressures exerted by these forces require companies' efforts in launch excellence to be able to 'square the circle' of better launch returns even as the launch environment becomes ever-more complex.
Join our webinar on 11 September 2019 from 11–12 BST to take a closer look at the past, present and future of pharmaceutical launches.
Register at https://www.brighttalk.com/webcast/9977/359268